Congenital Adrenal Hyperplasia or CAH is an inherited genetic disorder that affects the adrenal glands. Those with CAH lack one of the enzymes that the adrenal glands use to produce hormones that regulate metabolism, the immune system, blood pressure, and other essential functions. This can cause a number of symptoms, including accelerated puberty, infertility, and low blood pressure.
If you have lived with CAH since birth, you know how challenging it can be to manage everyday life in addition to this complicated condition. While there is currently no cure for CAH, treatment can help most people lead a normal life. If you’re interested in helping researchers discover a different way to help people with CAH, the CAHlibrate Study may be of interest to you.
The CAHlibrate Study – a clinical research study for CAH – is recruiting individuals ages 18–50 who have a clinical diagnosis of congenital adrenal hyperplasia. The CAHlibrate Study is evaluating the safety, tolerability, pharmacokinetics (movement of drugs in the body), and pharmacodynamics (effects of drugs in the body) of an investigational medication in adults with CAH.
If you or someone you know has congenital adrenal hyperplasia, learn more at CAHlibratestudy.com